Multiple Reaction Monitoring of mTRAQ-Labeled Peptides Enables Absolute Quantification of Endogenous Levels of a Potential Cancer Marker in Cancerous and Normal Endometrial Tissues
Leroi V. DeSouza(York University), K. W. Michael Siu(Shandong University), Marjorie Sue Minkoff(St. Michael's Hospital), Alexander D. Romaschin(Mount Sinai Hospital), Wěi Li(Shougang (China)), Adrian M. Taylor(St. Michael's Hospital), Terence J. Colgan(Mount Sinai Hospital)
Cited by 172
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
HIF-1α pathway: role, regulation and intervention for cancer therapy
|Acta Pharmaceutica Sinica B|2015|1.9k
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology
|Archives of Pathology & Laboratory Medicine|2012|999
The Lower Anogenital Squamous Terminology Standardization Project for HPV-associated Lesions
|International Journal of Gynecological Pathology|2012|568
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions
|Journal of Lower Genital Tract Disease|2012|491